Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial

Published:2021-02-04 Issue:2 Volume:26 Page:132-138
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Abbas Ahmed M.¹^ORCID,Abd Ellah Noura H.²,Hosny Maryt A.³,Abdellah Mohamed S.¹,Ali Mohammed K.¹

Affiliation:

1. Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt

2. Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt

3. Department of Obstetrics and Gynecology, Obstetrics, Gynecology and Pediatrics Hospital, Assiut, Egypt

Funder

Faculty of Medicine

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2020.1868427

Reference34 articles.

1. Effectiveness of Long-Acting Reversible Contraception

2. Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women

3. Interventions for the prevention of pain associated with the placement of intrauterine contraceptives: An updated review

4. Evaluating different pain lowering medications during intrauterine device insertion: a systematic review and network meta-analysis

5. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FSRH Guideline (March 2023) Intrauterine contraception;BMJ Sexual & Reproductive Health;2023-03